[go: up one dir, main page]

PE20030240A1 - DERIVADOS DE BENZO [g] QUINOLINA - Google Patents

DERIVADOS DE BENZO [g] QUINOLINA

Info

Publication number
PE20030240A1
PE20030240A1 PE2002000598A PE2002000598A PE20030240A1 PE 20030240 A1 PE20030240 A1 PE 20030240A1 PE 2002000598 A PE2002000598 A PE 2002000598A PE 2002000598 A PE2002000598 A PE 2002000598A PE 20030240 A1 PE20030240 A1 PE 20030240A1
Authority
PE
Peru
Prior art keywords
formula
alkyl
refers
compound
quinoline
Prior art date
Application number
PE2002000598A
Other languages
English (en)
Inventor
Rudolf Markstein
Peter Gull
Villar Esteban Pombo
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20030240A1 publication Critical patent/PE20030240A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/10Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A DERIVADOS DE BENZO g QUINOLINA DE FORMULA I DONDE A Y B SON H O FORMAN JUNTOS UN ENLACE ADICIONAL; X ES CH2, CO; Y ES O, S, NR2, (R2 SIENDO H O ALQUILO C1-C4) , CH2, O-CH2; R1 ES H, ALQUILO C1-C4 EN FORMA DE BASE LIBRE O SAL DE ADICION DE ACIDO. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION DEL COMPUESTO DE FORMULA I QUE INCLUYE EL PASO DE CONVERTIR EN UN COMPUESTO DE FORMULA II DONDE R3 ES ALQUILO C1-C4, EL GRUPO ALCOXILO EN UN GRUPO HIDROXILO Y RECUPERAR EL COMPUESTO ASI OBTENIDO DE FORMULA I. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. LA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE GLAUCOMA Y MIOPIA
PE2002000598A 2001-07-09 2002-07-03 DERIVADOS DE BENZO [g] QUINOLINA PE20030240A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01116553 2001-07-09

Publications (1)

Publication Number Publication Date
PE20030240A1 true PE20030240A1 (es) 2003-04-16

Family

ID=8177978

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000598A PE20030240A1 (es) 2001-07-09 2002-07-03 DERIVADOS DE BENZO [g] QUINOLINA

Country Status (25)

Country Link
US (1) US7105528B2 (es)
EP (1) EP1419149B1 (es)
JP (2) JP5006505B2 (es)
KR (2) KR101069948B1 (es)
CN (1) CN1293071C (es)
AR (1) AR036131A1 (es)
AT (1) ATE443060T1 (es)
AU (1) AU2002328856B2 (es)
BR (1) BR0210894A (es)
CA (1) CA2452920C (es)
DE (1) DE60233740D1 (es)
EC (1) ECSP024377A (es)
ES (1) ES2330732T3 (es)
HU (1) HUP0400833A3 (es)
IL (2) IL159255A0 (es)
MX (1) MXPA03012039A (es)
MY (1) MY130656A (es)
NO (1) NO327549B1 (es)
NZ (1) NZ530314A (es)
PE (1) PE20030240A1 (es)
PL (1) PL208284B1 (es)
PT (1) PT1419149E (es)
RU (1) RU2300532C2 (es)
WO (1) WO2003006458A1 (es)
ZA (1) ZA200309642B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG24415A (en) * 2002-03-07 2009-05-25 Novartis Ag Quinoline derivatives
WO2005023258A1 (en) * 2003-09-05 2005-03-17 Novartis Ag Compositions comprising benzo (g) quinoline derivatives and prostaglandin derivatives
RU2438670C1 (ru) * 2010-12-24 2012-01-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ростовский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО "РостГМУ" Минздравсоцразвития России) Способ лечения ишемического варианта первичной открытоугольной глаукомы у лиц с миопической рефракцией
TWI816716B (zh) 2017-11-24 2023-10-01 丹麥商H 朗德貝克公司 用於治療帕金森病之新兒茶酚胺前驅藥
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US12384765B2 (en) 2019-05-21 2025-08-12 H. Lundbeck A/S Catecholamine prodrugs for use in the treatment of Parkinson's Disease
EP3972959A1 (en) 2019-05-21 2022-03-30 H. Lundbeck A/S New catecholamine prodrugs for use in the treatment of parkinson's disease
US12319710B2 (en) 2019-05-21 2025-06-03 H. Lundbeck A/S Catecholamine prodrugs for use in the treatment of Parkinson's diseases
CN113727712B (zh) 2019-05-21 2024-11-15 H.隆德贝克有限公司 用于治疗帕金森病的儿茶酚胺氨基甲酸酯前药

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4114325A1 (de) * 1991-05-02 1992-11-05 Sandoz Ag Octahydrobenzo(g)chinolin, seine herstellung und verwendung
US5262422A (en) * 1991-05-02 1993-11-16 Sandoz Ltd. Octahydrobenzo[g]quinoline
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them

Also Published As

Publication number Publication date
RU2300532C2 (ru) 2007-06-10
MXPA03012039A (es) 2004-03-26
ATE443060T1 (de) 2009-10-15
KR20100007983A (ko) 2010-01-22
JP2004538278A (ja) 2004-12-24
NO327549B1 (no) 2009-08-10
PL208284B1 (pl) 2011-04-29
PT1419149E (pt) 2009-11-25
CA2452920C (en) 2010-03-30
AR036131A1 (es) 2004-08-11
NZ530314A (en) 2005-08-26
HUP0400833A2 (hu) 2004-07-28
EP1419149B1 (en) 2009-09-16
KR20040013126A (ko) 2004-02-11
RU2004102398A (ru) 2005-07-10
ECSP024377A (es) 2004-08-27
ES2330732T3 (es) 2009-12-15
KR101069948B1 (ko) 2011-10-04
BR0210894A (pt) 2004-06-22
IL159255A (en) 2010-05-17
AU2002328856B2 (en) 2005-08-04
MY130656A (en) 2007-07-31
HK1066211A1 (en) 2005-03-18
DE60233740D1 (de) 2009-10-29
NO20040059L (no) 2004-01-07
IL159255A0 (en) 2004-06-01
HUP0400833A3 (en) 2010-03-29
PL365254A1 (en) 2004-12-27
JP2010024243A (ja) 2010-02-04
WO2003006458A1 (en) 2003-01-23
EP1419149A1 (en) 2004-05-19
US7105528B2 (en) 2006-09-12
JP5006505B2 (ja) 2012-08-22
CN1293071C (zh) 2007-01-03
CA2452920A1 (en) 2003-01-23
CN1525969A (zh) 2004-09-01
US20040171628A1 (en) 2004-09-02
ZA200309642B (en) 2004-10-04

Similar Documents

Publication Publication Date Title
PE20030240A1 (es) DERIVADOS DE BENZO [g] QUINOLINA
AR018693A1 (es) MÉTODO PARA LA PREPARACIoN DE CITALOPRAM Y COMPUESTOS INTERMEDIARIOS PARA USO EN DICHO MÉTODO.
EA200301306A1 (ru) Производные 1-фенилсульфонил-1,3-дигидро-2h-индол-2-она, их получение и их терапевтическое применение
PE20020721A1 (es) Derivados de quinuclidina como agentes antimuscarinicos m3
SI2428519T1 (sl) Sestavek za pripravo 17-vinil-triflatov kot intermediatov
WO2007137030A3 (en) Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
PE20001467A1 (es) Derivados de 4-fenilpiridina como antagonistas del receptor de neuroquinina
PE1998A1 (es) DERIVADOS DE BENZO [g] QUINOLINA
PT87163A (pt) Process for preparing 1-phenyl-3-naphthalenyloxipropanamines
EA200300619A1 (ru) Серотонинергические средства
DE69924254D1 (de) Verwendung von a3-adenosine antagonisten zur herstellung eines arzneimittels zur senkung des augeninnendrucks
ES8801245A1 (es) Un procedimiento para preparar derivados de piperidina
KR880012227A (ko) 도파민 수용체 길항제의 신규사용법
KR950011444A (ko) 갈란타민 유도체, 이의 제조방법 및 약제로서의 이의 용도
PE20091182A1 (es) DERIVADOS DE IMIDAZO[1,2-a]PIRIDIN-2-CARBOXAMIDAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
PE20000724A1 (es) 1,2,3,4-tetrahidroquinolina
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
ES2172376A1 (es) Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR9807520A (pt) Derivados de 5-aroilnaftaleno.
BR0004548A (pt) Derivados i de quinolin-4-ila
PE20070120A1 (es) Derivados de prostaglandina
SE8804688D0 (sv) Substituerade styrenderivat
AR038730A1 (es) Derivados de quinolina
NO20006350L (no) Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer
KR960003719A (ko) 녹내장 치료제 및 안압 강하제

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed